← Back to Clinical Trials
Recruiting NCT07539363

NCT07539363 Effect of "RECAST-H" (REverse CAses STudies Based on Heutagogy Approach) on Professional Readiness

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07539363
Status Recruiting
Phase
Sponsor Hacettepe University
Condition Nurses Behaviors
Study Type INTERVENTIONAL
Enrollment 84 participants
Start Date 2026-04-09
Primary Completion 2026-06

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Reverse Case Studies based on Heutagogy Approach

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 84 participants in total. It began in 2026-04-09 with a primary completion date of 2026-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this study is to examine the effect of reverse case studies based on the heutagogical approach on the level of readiness for the profession among final-year nursing students. The hypotheses are: H0-1: There is no difference in the level of professional readiness between the control group and the intervention group that underwent reverse case studies based on the heutagogy approach. H0-2: There is no difference in career adaptability between the control group and the intervention group that underwent reverse case studies based on the heutagogy approach. H0-3: There is no difference in professional socialization between the control group and the intervention group that underwent reverse case studies based on the heutagogy approach. Secondary Hypothesis: H0-4: There is no difference in psychological capital levels between the control group and the intervention group that underwent reverse case studies based on the heutagogy approach. Researchers will compare the heutagogy-based reverse case studies program group with the waiting-list control group to evaluate its effects on professional readiness, career adaptability, professional socialization, and psychological capital. Participants will: * complete baseline assessments * be randomly assigned to either the intervention group or the waiting-list control group * receive reverse case studies program based on the heutagogy approach (intervention group) * complete post-intervention assessments after the educational program

Eligibility Criteria

Inclusion Criteria: * Being a final-year nursing student * Enrolled in "Education in Nursing" course * Willing to participate in the study Exclusion Criteria: * Graduated from vocational high school specializing in health services * Working full-time in any institution providing health services

Contact & Investigator

Central Contact

YILDIZ ERDAT

✉ yildizturunc@hacettepe.edu.tr

📞 +90312 305 15 80

Principal Investigator

SERGÜL DUYGULU

STUDY DIRECTOR

HACETTEPE UNİVERSITY

Frequently Asked Questions

Who can join the NCT07539363 clinical trial?

This trial is open to participants of all sexes, studying Nurses Behaviors. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07539363 currently recruiting?

Yes, NCT07539363 is actively recruiting participants. Contact the research team at yildizturunc@hacettepe.edu.tr for enrollment information.

Where is the NCT07539363 trial being conducted?

This trial is being conducted at Ankara, Turkey (Türkiye).

Who is sponsoring the NCT07539363 clinical trial?

NCT07539363 is sponsored by Hacettepe University. The principal investigator is SERGÜL DUYGULU at HACETTEPE UNİVERSITY. The trial plans to enroll 84 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology